IOSP insider Form 4 shows director increasing stake to 5,837 shares
Rhea-AI Filing Summary
Innospec Inc. director reports open-market stock purchase
A director of Innospec Inc. (IOSP) reported buying 340 shares of the company’s common stock on 11/14/2025 at a price of $74.09 per share. After this transaction, the director beneficially owns 5,837 shares, held as a direct ownership position. The transaction was reported on a Form 4 as a purchase coded "P" in the non-derivative securities table, and no derivative security transactions were reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 340 | $74.09 | $25K |
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Innospec Inc. (IOSP) report on this Form 4?
The filing reports that a director of Innospec Inc. (IOSP) purchased 340 shares of common stock on 11/14/2025.
What is the relationship of the reporting person to Innospec Inc. (IOSP)?
The reporting person is a director of Innospec Inc., as indicated in the relationship section of the filing.
Was this Innospec (IOSP) insider trade reported as a direct or indirect holding?
The 5,837 shares owned after the transaction are reported as a direct ownership position.
Does this Form 4 for Innospec (IOSP) report any derivative security transactions?
No derivative securities are listed as acquired or disposed of; only a purchase of common stock is reported in the non-derivative table.